ライフサイエンスコーパス: parainfluenza virus 5

1 sequence, FPIV, important for the budding of parainfluenza virus 5.

2 NASEK was dispensable for viruses, including parainfluenza virus 5 and Coxsackie B virus, that enter

3 athogens: human respiratory syncytial virus, parainfluenza virus 5, and Sendai virus.

4 ructed chimeras containing the ectodomain of parainfluenza virus 5 F (PIV5 F) and either the MPER, th

5 Here we report the crystal structure of the parainfluenza virus 5 F protein in its prefusion conform

6 ess the functional role of the paramyxovirus parainfluenza virus 5 F protein TM domain, alanine scann

7 Here, a soluble form of parainfluenza virus 5 F was triggered to refold using te

8 rystal structure of a fragment of the simian parainfluenza virus 5 fusion protein (SV5 F), revealing

9 , we show that the FP from the paramyxovirus parainfluenza virus 5 fusogenic protein, F, forms an N-t

10 ng globular head domain of the paramyxovirus parainfluenza virus 5 HN protein is entirely dispensable

11 usion activation, F activation involving the parainfluenza virus 5 HN stalk domain, and properties of

12 By modeling the crystal structure of parainfluenza virus 5 into the density, it is shown that

13 The paramyxovirus parainfluenza virus 5 mediates membrane merger through i

14 t robust maturation following infection with parainfluenza virus 5 or influenza virus.

15 hat Cav-1 colocalizes with the paramyxovirus parainfluenza virus 5 (PIV-5) nucleocapsid (NP), matrix

16 Parainfluenza virus 5 (PIV5) activates and is neutralize

17 For the paramyxoviruses parainfluenza virus 5 (PIV5) and mumps virus, M-NP inter

18 Proline substitution in this region of HN of parainfluenza virus 5 (PIV5) and Newcastle disease virus

19 In this work, we generated a recombinant parainfluenza virus 5 (PIV5) containing NP from H5N1 (A/

20 The paramyxovirus parainfluenza virus 5 (PIV5) enters cells by fusion of t

21 igh similarity to the structure of prefusion parainfluenza virus 5 (PIV5) F, with the main structural

22 Because only the prefusion structure of the parainfluenza virus 5 (PIV5) F-trimer is available, to s

23 MR spectroscopy, we show that the TMD of the parainfluenza virus 5 (PIV5) fusion protein adopts lipid

24 Parainfluenza virus 5 (PIV5) HN exists as a noncovalent

25 Parainfluenza virus 5 (PIV5) is a member of the Paramyxo

26 Parainfluenza virus 5 (PIV5) is a promising viral vector

27 Parainfluenza virus 5 (PIV5) is a prototypical paramyxov

28 Parainfluenza virus 5 (PIV5) is an appealing vector for

29 Parainfluenza virus 5 (PIV5) is an enveloped, single-str

30 The P protein of parainfluenza virus 5 (PIV5) is an essential cofactor of

31 Parainfluenza virus 5 (PIV5) is thought to contribute to

32 To investigate the role of NP protein in parainfluenza virus 5 (PIV5) particle formation, NP prot

33 In this work, we tested a recombinant parainfluenza virus 5 (PIV5) strain expressing the glyco

34 serendipitously identified a viral mRNA from parainfluenza virus 5 (PIV5) that activates IFN expressi

35 Preparations of parainfluenza virus 5 (PIV5) that are potent activators

36 quence variation of 16 different isolates of parainfluenza virus 5 (PIV5) that were isolated from a n

37 unable to be recognized by measles virus and parainfluenza virus 5 (PIV5) V proteins were tested in s

38 We tested the recombinant parainfluenza virus 5 (PIV5) vectors expressing RSV glyc

39 he threonine residue at position 286 of P of parainfluenza virus 5 (PIV5) was found phosphorylated.

40 The V proteins of measles virus (MV) and parainfluenza virus 5 (PIV5) were introduced into HFLC u

41 rotein (prefusion form) of the paramyxovirus parainfluenza virus 5 (PIV5) WR isolate was determined.

42 Parainfluenza virus 5 (PIV5), a paramyxovirus, is not kn

43 Similar results were also observed with parainfluenza virus 5 (PIV5), a paramyxovirus, when neut

44 Here we show that vaccination with parainfluenza virus 5 (PIV5), a promising live viral vec

45 Infection by parainfluenza virus 5 (PIV5), a prototypical member of t

46 The genome of parainfluenza virus 5 (PIV5), a prototypical paramyxovir

47 Parainfluenza virus 5 (PIV5), a prototypical paramyxovir

48 V), human parainfluenza virus 2 (hPIV2), and parainfluenza virus 5 (PIV5), all members of the genus R

49 Parainfluenza virus 5 (PIV5), formerly known as simian v

50 that a porcine isolate of the paramyxovirus parainfluenza virus 5 (PIV5), known as SER, requires a l

51 The strain diversity of a rubulavirus, parainfluenza virus 5 (PIV5), was investigated by compar

52 Previously, we developed two parainfluenza virus 5 (PIV5)-based RSV vaccine candidate

53 We previously generated a parainfluenza virus 5 (PIV5)-vectored vaccine candidate

54 In this study, we evaluated two parainfluenza virus 5 (PIV5)-vectored vaccines expressin

55 Similar results were also observed with parainfluenza virus 5 (PIV5).

56 he FP of the F protein of the paramyxovirus, parainfluenza virus 5 (PIV5).

57 f the matrix (M) protein of a paramyxovirus, parainfluenza virus 5 (PIV5).

58 -3 as a binding partner for the M protein of parainfluenza virus 5 (PIV5).

59 this study, we show that vaccination with a parainfluenza virus 5 recombinant vaccine candidate expr

60 Simian parainfluenza virus 5 (SV5) is a prototype of the Paramy

61 sion (F) protein of the paramxyovirus simian parainfluenza virus 5 (SV5) promotes virus-cell and cell

62 on (F) protein from the paramyxovirus simian parainfluenza virus 5 (SV5) resulted in mutant F protein

63 ined the ability of the paramyxovirus simian parainfluenza virus 5 (SV5) to affect cell cycle progres

64 recently published prefusogenic structure of parainfluenza virus 5/SV5 F places CBF(2) in direct cont

65 ed "stalk exposure model" first proposed for parainfluenza virus 5 to other paramyxoviruses and propo

66 A parainfluenza virus 5-vectored vaccine expressing the na